Approval of the Opdivo plus Yervoy combination regimen was based on results from the Phase III CheckMate-8HW trial, which was ...

The survey also suggests that Medicaid is broadly popular amongst all Americans, regardless of political affiliation.

Hyfe’s CEO Tamsin Chislett spoke with Pharmaceutical Executive about this new technology, along with how digital therapeutics ...

Brimochol PF, a combination of brimonidine and carbachol, was found to enhance depth of focus and visual acuity in clinical ...

We’re going to tariff our pharmaceuticals, and once we do that, they are going to come rushing back into our country," ...

LaShell Robinson, head of global feasibility and trial equity at Takeda, identifies some of the key barriers in achieving representative clinical trials for psoriasis, and how they are overcoming them ...

Amy Hessels, Bayer‘s vice president of marketing, talks about how to engage younger demographics and how the Your Decision campaign contributes to broader conversations about women's reproductive ...

Results from Phase II studies demonstrated that rilzabrutinib showed clinically meaningful outcomes in patients with warm ...

Results from the Phase III SPACE trial show that Ajovy significantly reduced monthly migraines in pediatric patients between ...

Family caregivers with both children and elderly family members to care for are reporting higher levels of burnout and mental ...

ProFuse Technology is a company focused on the development of muscle tissue in laboratory settings. The company recently ...

Enrollment for the Phase II trial follows FDA clearance of SPG302 Investigational New Drug application for schizophrenia.